“Rituris" the preparations of Rituximab 100 & 500 mg concentrated solution for IV infusion to treat Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CHL) and Rheumatoid Arthritis (RA). Rituris has the potential to address specific medical needs in oncology, increasing access to targeted therapies and maintaining a commitment to patients for improved cancer treatments that can help more patients receive the best care.
FR
DE